Leicestershire-based mobility provider NRS Healthcare has partly attributed a £20m boost in turnover to retaining a number of key clinical contracts this year.
The company, which supplies the NHS and deals direct to end-users, reported its turnover had risen to over £160m compared to nearly £140m in 2016 – a 15% increase.
Its pre-tax profits also grew to just over £5m, an increase on 2016’s £3.6m. The directors said they were “satisfied” with the performance and stated that 2017 had seen “continued success” for the group “in a growing and developing market”.
In the last year, NRS has kept hold of its integrated community equipment service (ICES) contracts in Berkshire and secured the Vale of York wheelchair service. The company also expanded into Lincolnshire and Powys with its telecare services and is eyeing further growth in ICES, wheelchair and clinical services.
Meanwhile, NRS’s product division saw record performance and growth and the company anticipates this will continue into the future.
NRS Healthcare received a £24m cash injection in 2013 from private equity house LDC as part of a management buyout. The following year, LDC sold part of its stake to H2 Equity Partners. In 2016 the group was ranked in the Sunday Times Grant Thornton Top Track 250.